Pharma

Supernus Pharmaceuticals

Supernus Pharmaceuticals (NASDAQ:SUPN) Reports 41% Shareholder Loss Amidst Five-Year Earnings Decline

For a lot of people, the main goal of investing is to make more money than what the entire market achieves. However, even someone who’s really good at picking stocks will only have some of their choices turn out successful. Right now, some people who invested in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) might be questioning their […]

Supernus Pharmaceuticals (NASDAQ:SUPN) Reports 41% Shareholder Loss Amidst Five-Year Earnings Decline Read More »

Lixte Biotechnology Holdings Inc (LIXT)

Lixte Biotechnology Holdings Inc (LIXT) is up 16.02% Thursday In Premarket Trading

LIXT stock ended the day at $3.87, and during pre-market trade, it has gone up $0.62. Since most buyers only trade during normal trading hours, pre-market tends to be more volatile than normal trading hours. LIXT has a low overall score of 19. This means that at its present price, the stock is worth less

Lixte Biotechnology Holdings Inc (LIXT) is up 16.02% Thursday In Premarket Trading Read More »

Scroll to Top